INVO Bioscience, Inc. filed its 10-K on Apr 17, 2023 for the period ending Dec 31, 2022. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8418 USD | -2.12% | -6.47% | -37.64% |
May. 15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-37.64% | 3.28M | |
-6.28% | 178B | |
-0.83% | 107B | |
-2.32% | 67.04B | |
-7.24% | 47.23B | |
+11.55% | 44.62B | |
+9.25% | 42.5B | |
+15.33% | 29.99B | |
+15.97% | 25.22B | |
-7.19% | 24.14B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- INVO Bioscience, Inc. Auditor Raises 'Going Concern' Doubt